Liver Transplantation — MCQs
In orthotopic liver transplantation, which is the best way to achieve bile drainage in the donor liver
HLA typing is useful in:
Transplantation of liver is contraindicated in:
Which of the following statements regarding rejection of solid organ transplants is true?
What is the documented mortality rate for healthy liver donors undergoing donor hepatectomy?
What does the MELD diagnostic score predict in patients awaiting liver transplantation?
Most common malignancy in post-transplant individuals:
All are Indications of liver transplant except
Which solid organ is considered to have the lowest risk of rejection during transplantation?
Most common indication for liver transplant in children:
Liver Transplantation Indian Medical PG Practice Questions and MCQs
Question 1: In orthotopic liver transplantation, which is the best way to achieve bile drainage in the donor liver
- A. Donor bile duct with recipient bile duct or Roux-en-Y choledochojejunostomy (Correct Answer)
- B. Donor bile duct with jejunum of recipient
- C. Donor bile duct with duodenum of recipient
- D. External drainage for a few days followed by choledochojejunostomy
Explanation: ***Donor bile duct with recipient bile duct or Roux en Y choledochojejunostomy*** - The most common and preferred method for bile drainage in **orthotopic liver transplantation** is a **duct-to-duct anastomosis** between the donor and recipient bile ducts. - If a primary duct-to-duct anastomosis is not feasible due to size mismatch, damage, or other reasons, a **Roux-en-Y choledochojejunostomy** is performed, which involves connecting the donor bile duct to a Roux limb of the jejunum. *External drainage for few days followed by choledochojejunostomy* - **External bile drainage** is generally avoided in liver transplantation due to increased risks of **infection** and complications like **bile leaks**. - It does not provide a definitive long-term solution for bile flow and necessitates a secondary, more complex surgical procedure for permanent drainage. *Donor bile duct with jejunum of recipient* - Connecting the donor bile duct directly to the jejunum (without a Roux-en-Y limb) would expose the biliary tree to **intestinal contents**, increasing the risk of **ascending cholangitis**. - The Roux-en-Y configuration is crucial to prevent reflux of food and bacteria into the biliary system, which is not achieved by a simple choledochojejunostomy. *Donor bile duct with duodenum of recipient* - Anastomosing the donor bile duct directly to the **duodenum** significantly increases the risk of **reflux of duodenal contents**, including digestive enzymes and bacteria, into the biliary system. - This reflux can lead to severe and recurrent **cholangitis**, stricture formation, and potential graft failure due to chronic inflammation and infection.
Question 2: HLA typing is useful in:
- A. Disputed paternity
- B. Dactylography
- C. Organ transplant (Correct Answer)
- D. Thanatology
Explanation: ***Organ transplant*** - **HLA typing** is crucial for **matching donors and recipients** in organ transplantation to minimize the risk of transplant rejection [1]. - A better **HLA match** between donor and recipient reduces the likelihood of the recipient's immune system attacking the transplanted organ [1]. *Disputed paternity* - While **HLA typing** was historically used, **DNA fingerprinting** (using STR markers) is now the primary and more accurate method for determining paternity [2]. - **DNA analysis** provides a higher probability of inclusion or exclusion and is less complex to interpret than HLA typing for paternity [2]. *Dactylography* - **Dactylography** refers to the study of fingerprints for **identification purposes**, a field entirely unrelated to genetic markers. - It involves analyzing the unique patterns of **ridges and valleys** on fingertips, not genetic typing. *Thanatology* - **Thanatology** is the scientific study of **death and dying**, including the psychological, social, and cultural aspects. - It does not involve genetic testing like **HLA typing** but rather focuses on end-of-life care, grief, and the processes surrounding death.
Question 3: Transplantation of liver is contraindicated in:
- A. Metastasis to liver (Correct Answer)
- B. Renal failure
- C. Acute fulminant liver disease
- D. Viral hepatitis
Explanation: ***Metastasis to liver*** - The presence of **metastasis to the liver** from another primary cancer is a general contraindication for liver transplantation. - This is because the underlying malignancy is systemic, and transplantation would not cure the cancer, with high risk of **disease recurrence** in the transplanted organ or elsewhere. *Renal failure* - **Renal failure** alone is not an absolute contraindication for liver transplantation; patients with **hepatorenal syndrome** or chronic kidney disease can undergo combined liver-kidney transplantation. - The decision depends on the reversibility of renal failure and the overall clinical picture. *Acute fulminant liver disease* - **Acute fulminant liver disease** is a common and often urgent **indication** for liver transplantation, not a contraindication. - Transplantation is life-saving in these cases when medical management fails due to rapid deterioration and high mortality. *Viral hepatitis* - **Viral hepatitis** (e.g., hepatitis C, hepatitis B) is a common cause of end-stage liver disease and is a leading **indication** for liver transplantation. - With modern antiviral therapies, patients can often receive a transplant and manage the viral recurrence post-transplant.
Question 4: Which of the following statements regarding rejection of solid organ transplants is true?
- A. Most immunosuppressive medications are used to prevent chronic rejection
- B. The major cause of graft failure is acute rejection
- C. Liver transplants are especially susceptible to hyperacute rejection
- D. Hyperacute rejection begins in the operating room with reperfusion of the transplanted organ (Correct Answer)
Explanation: ***Hyperacute rejection begins in the operating room with reperfusion of the transplanted organ*** - **Hyperacute rejection** is a rapidly-occurring immune response that starts almost immediately after the transplanted organ is re-vascularized, often while the patient is still in the operating room [1]. - This type of rejection is mediated by **pre-formed antibodies** (e.g., ABO blood group antibodies or anti-HLA antibodies) in the recipient's circulation that bind to antigens on the donor organ's endothelium, leading to massive thrombosis and organ destruction [1]. *Most immunosuppressive medications are used to prevent chronic rejection* - While immunosuppressants play a role in mitigating **chronic rejection**, their primary and most effective targets are **acute rejection episodes** and the initial prevention of organ rejection [2]. - **Chronic rejection** is often a more complex process involving both immune and non-immune factors, and current immunosuppressive regimens are less effective at completely preventing or reversing it compared to acute rejection. *The major cause of graft failure is acute rejection* - In the long term, **chronic rejection** (or chronic allograft dysfunction) is the leading cause of late graft loss, rather than acute rejection. - With advancements in immunosuppression, **acute rejection rates** have significantly decreased, making chronic issues and non-immune factors more prominent in overall graft failure. *Liver transplants are especially susceptible to hyperacute rejection* - **Liver transplants** are notably more tolerant to ABO and HLA mismatches compared to other solid organ transplants (like kidney or heart). - This relative immunotolerance means that **hyperacute rejection** is far less common in liver transplantation. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 241-242. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 180-181.
Question 5: What is the documented mortality rate for healthy liver donors undergoing donor hepatectomy?
- A. Mortality for donor is 0.6 to 0.8 %
- B. Mortality for donor is 0.5 %
- C. Mortality for donor is 0.2 to 0.4 % (Correct Answer)
- D. Mortality for donor is 1%
Explanation: ***Correct: Mortality for donor is 0.2 to 0.4%*** - Studies indicate that the **mortality rate** for healthy liver donors undergoing **donor hepatectomy** is very low, typically ranging from **0.2% to 0.4%**. - This rate reflects the extensive **pre-operative screening** and careful surgical techniques used to ensure donor safety. - Current data from major transplant centers worldwide support this range as the most accurate representation of donor risk. *Incorrect: Mortality for donor is 0.6 to 0.8%* - This range is **higher** than the generally accepted and documented mortality rates for healthy liver donors. - While complications can occur, fatal outcomes are rare, making this percentage an **overestimation** of actual risk. *Incorrect: Mortality for donor is 0.5%* - This mortality rate is also **higher** than the current reported rates for living liver donation in well-established centers. - Continuous advancements in surgical safety and donor selection have driven the mortality rate **below 0.5%** in most high-volume centers. *Incorrect: Mortality for donor is 1%* - A 1% mortality rate for healthy liver donors would be considered **unacceptably high** given the current standards of care. - This percentage severely **overestimates** the actual risks associated with living related liver donation and does not reflect modern surgical outcomes.
Question 6: What does the MELD diagnostic score predict in patients awaiting liver transplantation?
- A. Higher score - less mortality risk
- B. Predicts mortality risk for a 60 day period
- C. It is a 4 to 60 scale
- D. Predicts mortality in patients waiting for liver transplant (Correct Answer)
Explanation: ***Predicts mortality in patients waiting for liver transplant*** - The **Model for End-Stage Liver Disease (MELD)** score was developed to predict **mortality risk** in patients with severe liver disease [1]. - It is crucial for **prioritizing patients** on the liver transplant waiting list, ensuring those with the greatest immediate need receive organs first. *Higher score - less mortality risk* - A **higher MELD score** indicates **more severe liver disease** and a **higher risk of mortality**, not less [1]. - The scoring system is designed to identify patients who are most critically ill and therefore have a greater need for transplantation [1]. *Predicts mortality risk for a 60 day period* - The MELD score was originally developed to predict **3-month (90-day) mortality** in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) procedures. - While it's used for short-term prediction, 60 days is not the standard predictive period. *It is a 4 to 60 scale* - The MELD score typically ranges from **6 to 40**, although extreme clinical conditions can lead to scores outside this range in rare cases. - A score of 4 would be unusually low and not reflective of the calculated range based on its components.
Question 7: Most common malignancy in post-transplant individuals:
- A. Kaposi sarcoma
- B. PTLD
- C. CNS lymphoma
- D. Squamous cell carcinoma of skin (Correct Answer)
Explanation: Most common malignancy in post-transplant individuals: ***Squamous cell carcinoma of skin*** - **Squamous cell carcinoma (SCC) of the skin** is the most common malignancy in post-transplant individuals, largely due to **immunosuppression** which impairs immune surveillance against oncogenic viruses and sunlight-induced mutations [1]. - The risk of SCC is significantly increased (up to 65-fold) in transplant recipients, often presenting as **multiple tumors** and exhibiting a more aggressive course than in the general population [2]. *Kaposi sarcoma* - **Kaposi sarcoma (KS)** is associated with **human herpesvirus 8 (HHV-8)** infection and is more common in transplant recipients compared to the general population, but it is not the *most common* malignancy [1]. - While its incidence is increased, it remains less frequent than skin cancers like SCC. *PTLD* - **Post-transplant lymphoproliferative disorder (PTLD)** is a significant complication of organ transplantation, primarily driven by **Epstein-Barr virus (EBV)** infection in the setting of immunosuppression [1]. - PTLD is a serious malignancy, but its overall incidence is less than that of skin cancers. *CNS lymphoma* - **CNS lymphoma** can occur in post-transplant patients, often linked to **EBV infection** and immunosuppression [1]. - Although it is a severe complication, its incidence is considerably lower than that of skin cancers in this population.
Question 8: All are Indications of liver transplant except
- A. Biliary atresia
- B. Cirrhosis
- C. Fulminant hepatitis
- D. Cholangiocarcinoma (Correct Answer)
Explanation: ***Cholangiocarcinoma*** - **Cholangiocarcinoma** is a **contraindication** for liver transplantation due to its aggressive nature and high recurrence rate post-transplant, except in highly selected early cases treated with neoadjuvant therapy. - The risk of **tumor recurrence** and poor long-term survival generally outweighs the benefits of transplantation for this malignancy. *Biliary atresia* - **Biliary atresia** is the most common indication for **pediatric liver transplantation**. - It involves the progressive destruction of bile ducts, leading to **cholestasis**, cirrhosis, and liver failure in infants. *Cirrhosis* - **Cirrhosis** from various etiologies (e.g., viral hepatitis, alcohol, NASH) is a primary indication for liver transplantation when it leads to **decompensated liver disease** or end-stage liver failure. - Patients with complications like **ascites**, **encephalopathy**, or recurrent variceal bleeding often require transplant. *Fulminant hepatitis* - **Fulminant hepatitis** (acute liver failure) rapidly progresses to severe liver dysfunction and encephalopathy in individuals without pre-existing liver disease. - It is an urgent indication for **emergent liver transplantation** to prevent multi-organ failure and death.
Question 9: Which solid organ is considered to have the lowest risk of rejection during transplantation?
- A. Pancreas
- B. Kidney
- C. Heart
- D. Liver (Correct Answer)
Explanation: ***Liver*** - The liver has a unique immunologic environment, often referred to as **immunologic privilege**, which contributes to its lower rates of rejection compared to other transplanted solid organs. - It produces various **immunosuppressive factors** and has a high capacity for regeneration and repair, adapting more readily to the recipient's immune system. - The liver's **dual blood supply** (hepatic artery and portal vein) and tolerogenic properties make it the most immunologically privileged solid organ. *Pancreas* - **Pancreas transplantation** carries a high risk of rejection, with rejection rates significantly higher than liver transplantation. - Pancreatic tissue is highly **immunogenic** due to its endocrine and exocrine functions, requiring aggressive immunosuppression. - Often transplanted with kidney in diabetic patients, and rejection episodes are common. *Kidney* - Kidney transplantation is common, but it carries a significant risk of both **acute and chronic rejection**, requiring lifelong immunosuppression. - The kidney expresses various **MHC antigens** that are readily recognized by the recipient's immune system, making it more immunogenic than the liver. *Heart* - **Heart transplantation** is associated with a high risk of rejection due to the rich vascularity and immunogenicity of cardiac tissue. - It often requires aggressive immunosuppressive regimens to prevent both **acute cellular rejection** and **antibody-mediated rejection**.
Question 10: Most common indication for liver transplant in children:
- A. Biliary atresia (Correct Answer)
- B. Drug reactions
- C. Cirrhosis
- D. Hepatitis
Explanation: ***Biliary atresia*** - **Biliary atresia** is a progressive, inflammatory obliterative cholangiopathy that affects the extrahepatic biliary tree, leading to cholestasis and liver damage. It accounts for the majority of pediatric liver transplants. - If untreated, it rapidly progresses to **cirrhosis** and **liver failure**, making transplantation a necessary intervention for survival. *Drug reactions* - While severe **drug-induced liver injury** can necessitate a liver transplant, it is a relatively rare cause in children compared to other conditions. - Many drug reactions can be managed with supportive care or by discontinuing the offending agent, without progressing to end-stage liver disease requiring transplant. *Cirrhosis* - **Cirrhosis** is the end-stage result of many chronic liver diseases, including biliary atresia, rather than a primary indication itself in children. - While children with cirrhosis ultimately require transplant, the underlying cause of the cirrhosis (like **biliary atresia**) is often the specific primary indication. *Hepatitis* - Acute or chronic viral **hepatitis** (e.g., Hepatitis A, B, C) can lead to liver failure, but it is less common for hepatitis to be the primary cause of liver transplant in children than biliary atresia. - Many cases of hepatitis, especially in children, resolve spontaneously or are managed medically, and only a subset progresses to severe liver failure requiring transplantation.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free